Aging Well Podcast

Episode 166: Treating age-related macular degeneration w/ Drs. Kai Chan and Andrew Dick (Cirrus Therapeutics)

July 14, 2024 Jeff Armstrong Season 3 Episode 49
Episode 166: Treating age-related macular degeneration w/ Drs. Kai Chan and Andrew Dick (Cirrus Therapeutics)
Aging Well Podcast
More Info
Aging Well Podcast
Episode 166: Treating age-related macular degeneration w/ Drs. Kai Chan and Andrew Dick (Cirrus Therapeutics)
Jul 14, 2024 Season 3 Episode 49
Jeff Armstrong

Send us a Text Message.

In this episode, we explore the impact of age-related macular degeneration (AMD) on vision and overall quality of life. Dr. Armstrong and Corbin Bruton are joined by Drs. Kai Chan and Andrew Dick, founders of Cirrus Therapeutics, to discuss the complexities of AMD, its risk factors, and current treatment options. They delve into a groundbreaking novel therapy developed by Cirrus Therapeutics that uses genetic instructions to produce the protein IRAK-M, offering new hope for protecting against retinal degeneration. Tune in to learn more about AMD, its prevention, the promising advancements in ocular immunology that aim to restore vision for millions, and the complex interactions between vision health and… aging well.

Related Articles:

Researchers unveil pioneering approach to combat age-related vision loss

Jian Liu et al. (2024). Replenishing IRAK-M expression in retinal pigment epithelium attenuates outer retinal degeneration. Science Translational Medicine, 16: eadi4125. DOI:10.1126/scitranslmed.adi4125 

TruDiagnostic epigenetic testing
Get a 12% discount using promo code (AGEWELL) and track your pace of aging well.

Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.

Support the Show.

Have questions you want answered and topics you want discussed on the Aging Well Podcast? Send us an email at agingwell.podcast@gmail.com or record your question for us to use in an upcoming episode:
https://www.speakpipe.com/AgingWellPodcast

Aging Well Podcast +
Subscribe and help support the Aging Well Podcast!!
Starting at $3/month
Support
Show Notes

Send us a Text Message.

In this episode, we explore the impact of age-related macular degeneration (AMD) on vision and overall quality of life. Dr. Armstrong and Corbin Bruton are joined by Drs. Kai Chan and Andrew Dick, founders of Cirrus Therapeutics, to discuss the complexities of AMD, its risk factors, and current treatment options. They delve into a groundbreaking novel therapy developed by Cirrus Therapeutics that uses genetic instructions to produce the protein IRAK-M, offering new hope for protecting against retinal degeneration. Tune in to learn more about AMD, its prevention, the promising advancements in ocular immunology that aim to restore vision for millions, and the complex interactions between vision health and… aging well.

Related Articles:

Researchers unveil pioneering approach to combat age-related vision loss

Jian Liu et al. (2024). Replenishing IRAK-M expression in retinal pigment epithelium attenuates outer retinal degeneration. Science Translational Medicine, 16: eadi4125. DOI:10.1126/scitranslmed.adi4125 

TruDiagnostic epigenetic testing
Get a 12% discount using promo code (AGEWELL) and track your pace of aging well.

Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.

Support the Show.

Have questions you want answered and topics you want discussed on the Aging Well Podcast? Send us an email at agingwell.podcast@gmail.com or record your question for us to use in an upcoming episode:
https://www.speakpipe.com/AgingWellPodcast